ASCO 2024: 3 Key Takeaways For Biopharma Companies
The American Society of Clinical Oncology wrapped its 2024 Annual Meeting earlier this month. This 40,000+ attendee event is the forum for oncology stakeholders to discuss research, practice, quality of care, technology and policy, all with an eye toward the future of oncology care. What can companies looking to bring new and transformative treatments to […]
